Lee Ainslie - Maverick Capital Ltd
Holding/activity history for Pacira Biosciences Inc (PCRX)
| Period | Shares | % of Portfolio | Activity | % Change to Portfolio | Reported Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2023 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2023 Q2 | 5,823 | <0.01 | Buy | <0.01 | $40.07 | $233,328 | SEC |
| 2021 Q3 | 0 | 0.00 | Sell 100.00% | <0.01 | SEC | ||
| 2021 Q2 | 1,108 | <0.01 | Buy | <0.01 | $60.47 | $67,000 | SEC |
| 2020 Q2 | 0 | 0.00 | Sell 100.00% | 0.03 | SEC | ||
| 2020 Q1 | 48,159 | 0.03 | Reduce 52.42% | 0.04 | $33.53 | $1,615,000 | SEC |
| 2019 Q4 | 101,219 | 0.07 | Reduce 41.28% | 0.04 | $45.30 | $4,585,000 | SEC |
| 2019 Q3 | 172,380 | 0.10 | Buy | 0.10 | $38.07 | $6,563,000 | SEC |
| 2016 Q2 | 0 | 0.00 | Sell 100.00% | 1.35 | SEC | ||
| 2016 Q1 | 1,610,932 | 1.35 | Buy | 1.35 | $52.98 | $85,347,000 | SEC |